Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Tuesday, RBC Capital Markets reiterated their Outperform rating on Keurig Dr Pepper shares (NASDAQ:KDP), maintaining a $42.00 price target. The firm’s analysts highlighted the company’s growth drivers, noting solid performance in the US Refreshment Beverages sector, bolstered by both a strong base business and increasing contributions from partner brands and GHOST energy drinks. The company’s impressive 55.56% gross profit margin and consistent dividend growth over the past four years support this positive outlook. However, they also observed a continued soft performance in the coffee segment. InvestingPro analysis reveals 8 additional key insights about KDP’s financial health and growth prospects.
RBC Capital Markets anticipates that Keurig Dr Pepper will mirror its previous solid results, aligning with consensus expectations for the first quarter. With earnings scheduled for April 24, InvestingPro data shows net income is expected to grow this year, though 6 analysts have recently revised their earnings expectations downward. The analysts perceive a neutral risk-reward profile for the company at this juncture. Despite the softness in coffee, the firm believes that Keurig Dr Pepper has clear asymmetric growth drivers in place.
The recent strong relative performance of Keurig Dr Pepper’s stock was noted as setting a higher bar for the upcoming quarter. According to RBC Capital Markets, the stock’s outperformance year-to-date has created a more challenging environment for continued growth in the short term.
Nevertheless, RBC Capital Markets continues to favor Keurig Dr Pepper as one of their top picks for the year. They expect the company to leverage its strengths in the refreshment beverage sector to sustain its growth trajectory, despite the hurdles posed by the recent outperformance and the underwhelming coffee sales.
The firm’s analysts concluded their commentary by reaffirming their positive stance on Keurig Dr Pepper, underscoring the company’s potential to maintain its robust performance in the beverage industry.
In other recent news, Keurig Dr Pepper has been the focus of several significant developments. The company announced the resignation of three board members, Joachim Creus, Frank Engelen, and Olivier Goudet, following a public secondary offering of 73 million shares, which generated approximately $2.7 billion in gross proceeds. Additionally, J.P. Morgan Securities LLC exercised an option to purchase an extra 10.95 million shares. In analyst updates, Argus initiated coverage with a Buy rating and a $40 price target, citing the company’s strong market position and undervaluation compared to peers. Morgan Stanley (NYSE:MS) also upgraded the stock from ’Equalweight’ to ’Overweight,’ raising their price target to $40, highlighting Keurig Dr Pepper’s growth prospects and market share gains. Furthermore, the company is navigating potential regulatory challenges as a proposal to ban soda purchases with food stamps gains traction, which could impact future sales. Despite these concerns, Keurig Dr Pepper was noted in a Piper Sandler survey as a top favorite among teens, particularly with Dr Pepper ranking highly. These developments reflect ongoing changes and challenges for the company in both market positioning and governance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.